Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomegranate extract oral formulation for benign prostatic hyperplasia
IRCT20200408046990N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2020
- Countries
- 1
01
Overview
Phase 3 trial of POMx in benign prostatic hyperplasia (BPH), sponsored by Mashhad University of Medical Sciences. Started Jul 2020; status: completed.
02
Drugs
POMx
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20200408046990N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046990N4.